LipimetiX

Small peptide Apo E mimetics direct free LDL to receptors on the liver and then fecal elimination. Strong animal data, ready for clinic with FDA accepted markers for efficacy. Lead indications: severely high cholesterol (Type II and Type III dyslipidemias) and acute coronary syndrome